Suppr超能文献

人类肝癌发生过程中酒精滥用和肝炎感染的表观遗传特征。

Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.

作者信息

Hlady Ryan A, Tiedemann Rochelle L, Puszyk William, Zendejas Ivan, Roberts Lewis R, Choi Jeong-Hyeon, Liu Chen, Robertson Keith D

机构信息

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. Cancer Center, Georgia Regents University, Augusta, GA, USA.

出版信息

Oncotarget. 2014 Oct 15;5(19):9425-43. doi: 10.18632/oncotarget.2444.

Abstract

Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide. Deregulated DNA methylation landscapes are ubiquitous in human cancers. Interpretation of epigenetic aberrations in HCC is confounded by multiple etiologic drivers and underlying cirrhosis. We globally profiled the DNA methylome of 34 normal and 122 liver disease tissues arising in settings of hepatitis B (HBV) or C (HCV) viral infection, alcoholism (EtOH), and other causes to examine how these environmental agents impact DNA methylation in a manner that contributes to liver disease. Our results demonstrate that each 'exposure' leaves unique and overlapping signatures on the methylome. CpGs aberrantly methylated in cirrhosis-HCV and conserved in HCC were enriched for cancer driver genes, suggesting a pathogenic role for HCV-induced methylation changes. Additionally, large genomic regions displaying stepwise hypermethylation or hypomethylation during disease progression were identified. HCC-HCV/EtOH methylomes overlap highly with cryptogenic HCC, suggesting shared epigenetically deregulated pathways for hepatocarcinogenesis. Finally, overlapping methylation abnormalities between primary and cultured tumors unveil conserved epigenetic signatures in HCC. Taken together, this study reveals profound epigenome deregulation in HCC beginning during cirrhosis and influenced by common environmental agents. These results lay the foundation for defining epigenetic drivers and clinically useful methylation markers for HCC.

摘要

肝细胞癌(HCC)是全球第二大常见癌症死因。DNA甲基化格局失调在人类癌症中普遍存在。HCC中表观遗传畸变的解释因多种病因驱动因素和潜在的肝硬化而变得复杂。我们全面分析了34份正常组织以及122份由乙型肝炎(HBV)或丙型肝炎(HCV)病毒感染、酒精中毒(EtOH)及其他病因引起的肝病组织的DNA甲基化组,以研究这些环境因素如何以导致肝病的方式影响DNA甲基化。我们的结果表明,每种“暴露”都会在甲基化组上留下独特且重叠的特征。在肝硬化 - HCV中异常甲基化且在HCC中保守的CpG富集了癌症驱动基因,这表明HCV诱导的甲基化变化具有致病作用。此外,还鉴定出在疾病进展过程中显示出逐步高甲基化或低甲基化的大片基因组区域。HCC - HCV/EtOH甲基化组与隐源性HCC高度重叠,这表明肝癌发生过程中存在共同的表观遗传失调途径。最后,原发性肿瘤和培养肿瘤之间重叠的甲基化异常揭示了HCC中保守的表观遗传特征。综上所述,本研究揭示了HCC从肝硬化阶段开始就存在深刻的表观基因组失调,且受常见环境因素影响。这些结果为确定HCC的表观遗传驱动因素和临床上有用的甲基化标记奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da86/4253444/d74dc82e617c/oncotarget-05-9425-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验